- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $73.02M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $271.57M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $180.43M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $407.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $446.83M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $23.98M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $22.46M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $98.68M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $24.54M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $506.26M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $474.29M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $511.26M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $477.93M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 62.64M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $212K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$14.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $6.81M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $13.01M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$13.67M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$19.82M |